Assessing bone pain and survival in SWOG Cancer Research Network 1216 TAK700 in hormone sensitive prostate cancer

Sumanta K.Pal shared a post on X about a recent paper by Georges Gebrael et al., commenting: 

“Proud of Georges Gebrael, University of Utah Department of Internal Medicine and Neeraj Agarwal, Huntsman Cancer Institute for a terrific paper in JAMA Network Open assessing bone pain and survival in SWOG Cancer Research Network 1216, a trial of TAK700 in hormone sensitive prostate cancer.”

Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial published in National Library of Medicine.

Authors: Yeonjung Jo, Umang Swami, Melissa Plets, Chadi Hage Chehade, Arshit Narang, Shilpa Gupta, Zin W Myint, Nicolas Sayegh, Catherine M Tangen, Maha Hussain, Tanya Dorff, Primo N Lara Jr, Seth P Lerner, Ian Thompson, Neeraj Agarwal.

Additional information
Source: Sumanta K. Pal/X

Sumanta (Monty) Pal, MD, is a medical oncologist and an expert in genitourinary cancers at the City of Hope Comprehensive Cancer Center in Los Angeles. He serves as the co-director of the Kidney Cancer Program and leads the Kidney and Bladder Cancer Disease Team at City of Hope. He specialises in kidney, bladder, and prostate cancers.